Summary

A randomized, double-blind, placebo-controlled study from researchers in Brazil and Australia has demonstrated the prowess of N-acetylcysteine (NAC) in reducing cigarette smoking for individuals previously refractory to smoking cessation efforts. Although the small number of patients precludes a definite conclusion, the potential of NAC in smoking cessation therapy is indicated [APA 2014 (poster NR-8218)].